It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ultra-small gold nanoparticles (Au-NPs) “≤ 10 nm diameters” have potent biomedical applications. Hence, the present study aimed to greenly synthesize ultra-small gold nanoparticles using Egyptian propolis extract. Different biological activities, in vivo bio-distribution and acute toxicity study were assessed. Results revealed that, Egyptian propolis extract can successfully synthesize the highly pure and stable ultra-small Au-NPs with average diameter 7.8 nm. In vitro antimicrobial and antimycobacterial activities revealed the powerful effect of the prepared Au-NPs. Moreover, the cytotoxic effect on human cancer cell lines revealed the potent inhibition of the cancer cells’ proliferation with high reactive oxygen species-mediated apoptosis induction. In vivo bio-distribution and acute toxicity studies were performed (10 and 100 mg/kg doses) in male albino rats. The ultra-small Au-NPs showed low or no toxicity upon using the Au-NPs low dose. The mean area accumulation (%) of the Au-NPs was higher in the liver, kidney, and brain tissues (4.41, 2.96, and 0.3 times, respectively) treated with high Au-NPs dosage compared to those treated with the low dose. Surprisingly, Au-NP accumulation in brain tissue was observed in the glial cells only. Accordingly, the low dose (10 mg/kg) of Au-NPs can be used safely in a variety of biomedical applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Taibah University, Chemistry Department, Faculty of Science, Medina, Saudi Arabia (GRID:grid.412892.4) (ISNI:0000 0004 1754 9358)
2 Alexandria University, Botany & Microbiology Department, Faculty of Science, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941)
3 Alexandria University, Zoology Department, Faculty of Science, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941)
4 Pharos University in Alexandria, Medical Laboratory Technology Department, Faculty of Applied Health Sciences Technology, Alexandria, Egypt (GRID:grid.442603.7) (ISNI:0000 0004 0377 4159)
5 City of Scientific Research and Technological Applications (SRTA-City), Medical Biotechnology Department, Genetic Engineering and Biotechnology Research Institute, New Borg El Arab, Egypt (GRID:grid.420020.4) (ISNI:0000 0004 0483 2576)
6 Alexandria University, Biochemistry and Molecular Biology Department, Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941)